Brandt Delhamer, M.D. (left), CEO Jalil Thurber, M.D., (center) and Mazyar Rouhani, M.D. (right), started a company called Symptify which helps users figure out causes for their symptoms, what to do about them and where to go for help. | PETER ANDREW BOSCH MIAMI HERALD STAFF
Company name: Symptify
Headquarters: Sunny Isles Beach
Concept: Symptify is a virtual doctor. It helps users figure out causes for their symptoms, what to do about them and where to go for help.
Story: As emergency physicians, Symptify’s co-founders have seen many people make needless and costly ER visits after “Googling” their symptoms online. In many cases, an online search for answers actually led to an unfounded escalation of fears. A recent study by Microsoft found that the medical content on the Internet is skewed toward more serious conditions. This is part of the reason why “Googling” your symptoms is not the best way to arrive at a diagnosis.
The Symptify team created a proprietary, patent-pending algorithmic engine that renders virtual consultations by asking users a series of questions regarding their symptoms. Because Symptify takes into account a user’s own medical history, it gives personalized and precise results. This has helped many people become more knowledgeable regarding their health conditions, helping them avoid “cyberchondria.” Symptify also facilitates a user’s access to healthcare providers by allowing the person to transmit his or her consultation record and medical profile to participating facilities.
“Ninety million Americans go online to self-diagnose their symptoms. But they didn’t have an app for that, so we made one,” said Dr. Jalil Thurber, CEO of Symptify.
Management team: Co-founders Dr. Jalil Thurber, CEO; Dr. Mazyar Rouhani, COO; Dr. Brandt Delhamer, CCO; Nicola Mazola, CTO; Pierre Schiro, CIO.
Number of employees: Three developers.
Financing:. The company has been funded by its founders, who have provided $1.5 million in cash and services. Seeking $2 million in additional seed funding.
Recent milestones reached: Won the eMerge Americas Startup Showcase for early-stage companies, and through that victory Symptify obtained first outside investment of $50,000. Participated in Miami’s first Healthbox Studio, a program that was sponsored by Florida Blue. Last year signed up 10 emergency rooms that renewed their contracts three months ago. Launched a Spanish version of the platform in May. Launched a doctor appointment scheduler app in February and several physicians have enrolled for this service.
Biggest startup challenge: Raising capital in South Florida.
Next step: “We have a large sales funnel and anticipate that we will announce partnerships with large and well recognized brands soon,” said Thurber.
Strategy for next step: Continue building Symptify’s brand, which emphasizes the functionality and ease of its unique medical self-assessment platform. The end goal is to brand Symptify as synonymous with an online “virtual doctor” and essentially create a new paradigm through which users self-diagnose their symptoms online, Thurber said.
Advisor’s view: “This is a company founded by people with deep subject matter expertise. That's exciting and not necessarily common. Their company is solving a real problem and will have meaningful impact on probably the most important thing in life, our health,” said Payam Zamani, board member of Symptify and chairman of Reply! Inc. “The core technology and the highly intelligent platform that allows you to diagnose yourself using your smart phone is light years ahead of anything else out there.”